ARTICLE | Company News
Medarex, Xerion Pharmaceuticals GmbH deal
January 26, 2004 8:00 AM UTC
MEDX and Xerion partnered to develop human antibodies. Under the deal, Xerion will use its Xstream technology to identify targets, against which MEDX will use its UltiMab Human Antibody Development Sy...